ATR
AptarGroup, Inc.122.83
+0.50+0.41%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
8.09BP/E (TTM)
19.72Basic EPS (TTM)
6.23Dividend Yield
0.01%Recent Filings
8-K
8-K
10-Q
Q2 FY2025 results
AptarGroup posted solid Q2 results, with net sales climbing 6% year-over-year to $966M, fueled by 3% core growth amid a favorable 3% currency tailwind. Operating income rose 15% to $144M, lifting margins to 15.0% from 13.8%, thanks to stronger Pharma and Closures volumes plus better operational efficiency. Diluted EPS hit $1.67, up 25% from $1.34, aligning neatly with 67,048 average shares. Cash from operations dipped to $209M year-to-date, yielding $92M free cash flow after $120M capex, while net debt edged up to $917M against $2.7B equity. A small acquisition wrapped up, adding minor goodwill. Yet competition in beauty and pharma dispensing keeps pressure on pricing.
8-K
Aptar Q2 sales rise 6%
AptarGroup reported Q2 2025 sales up 6% to $966 million, with net income surging 24% to $112 million and adjusted EBITDA climbing 13% to $218 million, boosting margins to 22.6%. Pharma and Closures segments led growth via higher volumes in injectables and food packaging, while Beauty lagged on subdued fragrance launches. All units expanded EBITDA margins. Returned $100 million to shareholders. Q3 adjusted EPS guidance: $1.53-$1.61, tempered by naloxone normalization.
8-K
Plan amendment approved
AptarGroup stockholders approved an amendment to the 2018 Equity Incentive Plan at the May 7, 2025 annual meeting, adding 1,000,000 shares for future grants. All three director nominees sailed through with overwhelming support, while executive pay and auditor ratification passed handily too. This bolsters talent retention amid growth. No hit to current shares outstanding.
IPO
Website
Employees
Sector
Industry
ABT
Abbott Laboratories
126.86-1.61
ATRC
AtriCure, Inc.
41.08+0.04
AVTR
Avantor, Inc.
11.20-0.08
BAX
Baxter International Inc.
19.05-0.48
COSM
Cosmos Health Inc.
0.50+0.09
RVP
Retractable Technologies, Inc.
0.82-0.01
SHTPY
-
7.65+0.00
STVN
Stevanato Group S.p.A.
20.89-0.41
UFPT
UFP Technologies, Inc.
217.74-0.08
WST
West Pharmaceutical Services, I
266.44-5.42